Dr. Meg Mooney helps coordinate cancer clinical trial networks across the country and internationally, and also organizes initiatives related to innovative cancer treatment reviews and precision medicine. In this episode, Mooney discusses a new natural history study the National Cancer Institute launched for cancer patients with COVID-19, as well as the work being done in drug discovery and development during this time.
HealthCast
Season 1
Episode 10
18m listen
Dr. Meg Mooney, Associate Director of CTEP, NCI
Share
The office coordinates nationwide testing of new treatment approaches for cancer.
-
Meg Mooney Associate Director of CTEP NCI
Related Content
-
Inside ASPR’s Efforts to Bolster Healthcare Sector Cyber Resilience
HHS ASPR’s Bob Bastani details how governance, standards and migration planning can help against emerging threats to medical data and devices.
12m watch -
Building Resilient Teams: Culture Eats Strategy for Breakfast
Jamie Holcombe shares how trust, mission clarity and employee well-being help leaders build resilient teams and sustain innovation.
24m watch -
Streamlining the ATO Process Makes Software Deployments More Efficient, Secure
NIST’s Victoria Yan Pillitteri discusses common ATO stumbling blocks and how agencies can streamline authorization for secure software deployment.
7m watch -
This National Lab is Using Multi-Agent AI to Accelerate Scientific Discovery
SLAC’s John Sarrao details how AI is accelerating materials discovery and reshaping collaboration across national labs and federal agencies.
21m watch
